The use of hormonal therapy with radiotherapy for prostate cancer: Analysis of prospective randomised trials

22Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In 1901, Wilhelm Conrad Röntgen won the Nobel prize in Physics for his discovery of the Röntgen rays or, as he himself called them, X-rays. In 1966, Dr Charles Brenton Higgins won the Nobel Prize in Medicine for his breakthroughs concerning hormonal treatment of prostatic cancer. After 31 years, in 1997, the first prospective randomised trials of the combination of hormonal therapy and radiation therapy were published, showing increased survival when compared to radiation therapy alone for patients with prostate cancer. Since 1997, many investigators have published trials combining hormonal and radiation therapy for prostate cancer. This minireview will address the largest and most influential of these trials, and attempt to guide physicians in selecting the appropriate patients for this combined approach. © 2004 Cancer Research UK.

Cite

CITATION STYLE

APA

Gottschalk, A. R., & Roach, M. (2004, March 8). The use of hormonal therapy with radiotherapy for prostate cancer: Analysis of prospective randomised trials. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6601625

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free